See More Clearly on the Edge

Curated by leading GEN reporters, GEN Edge is the premium subscription service for exclusive news and insights of critical interest to biotech industry executives and life science professionals. GEN Edge goes beyond the headlines and cuts through the noise to give early insight into how, when, and why the latest biotech developments will impact future outcomes and investments to keep you ahead of the competition and on the bleeding-edge of biotech.

Subscribers receive exclusive access to a host of insider content as only the GEN team can deliver it, including in-depth reporting, profiles of new and emerging companies, market analyses, early indicator intel, Market Insights Reports, and dynamic invitation-only events.

Start Your 30-Day Free Trial Now

Zero Risks. All the Rewards.

GET STARTED

Your Edge on the Competition

A GEN Edge Subscription Delivers:

In-depth reporting and detailed analysis

of breaking business developments, investments, acquisitions, takeovers, partnerships, patent disputes, regulatory filings, and more

Exclusive interviews

with biotech CEOs, founders, KOLs, and other newsmakers on what makes the industry tick

Provocative opinion pieces and guest commentaries

from biotech leaders and entrepreneurs

Profiles and success stories

of exciting new biotech start-ups and established companies across North America and around the world

Instant access to the complete GEN Edge archive

of more than 100 exclusive stories and interviews

Embargoed access to the A-Lists

GEN’s exclusive lists of top drugs, companies, movers and shakers, and biotech clusters, one full week before public release

Free registration for GEN Edge Live

our real-time interactive broadcast series featuring GEN Edge Senior Editors and high-profile biotech newsmakers

Access to Close to the Edge

a dynamic video series of exclusive CEO interviews, spotlighting the current and next generation of biotech leaders

Free GEN Market Insights Report

with in-depth data and information on cutting-edge trends in biotech, plus preferred discounts on additional GEN Market Insights Report

Breaking news alerts and weekly digest eNewsletters

to keep you in the know 24/7

Complimentary access to impactful articles

from market-leading peer-review journals, including Biotechnology Law Report, The CRISPR Journal, and Human Gene Therapy

START YOUR FREE TRIAL NOW

Have more questions? Check out our FAQs.

Copyright © 2022 Genetic Engineering & Biotechnology News. All Rights Reserved.